A Phase II Randomized Clinical Trial of Intravitreal Bevacizumab for Diabetic Macular Edema
Top Cited Papers
- 31 October 2007
- journal article
- research article
- Published by Elsevier BV in Ophthalmology
- Vol. 114 (10), 1860-1867.e7
- https://doi.org/10.1016/j.ophtha.2007.05.062
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Reproducibility of Macular Thickness and Volume Using Zeiss Optical Coherence Tomography in Patients with Diabetic Macular EdemaOphthalmology, 2007
- Comparison of the Modified Early Treatment Diabetic Retinopathy Study and Mild Macular Grid Laser Photocoagulation Strategies for Diabetic Macular EdemaAmerican Journal of Ophthalmology, 2007
- Relationship between Optical Coherence Tomography–Measured Central Retinal Thickness and Visual Acuity in Diabetic Macular EdemaOphthalmology, 2007
- Effect of Ruboxistaurin on Visual Loss in Patients with Diabetic RetinopathyOphthalmology, 2006
- INTRAVITREAL BEVACIZUMAB (AVASTIN) THERAPY FOR PERSISTENT DIFFUSE DIABETIC MACULAR EDEMARetina, 2006
- A Pilot Study of Multiple Intravitreal Injections of Ranibizumab in Patients with Center-Involving Clinically Significant Diabetic Macular EdemaOphthalmology, 2006
- Ranibizumab for Neovascular Age-Related Macular DegenerationThe New England Journal of Medicine, 2006
- A Phase II Randomized Double-Masked Trial of Pegaptanib, an Anti–Vascular Endothelial Growth Factor Aptamer, for Diabetic Macular EdemaOphthalmology, 2005
- Variability of full-field electroretinogram responses in subjects without diffuse photoreceptor cell diseaseOphthalmology, 2003
- A computerized method of visual acuity testing: Adaptation of the early treatment of diabetic retinopathy study testing protocolAmerican Journal of Ophthalmology, 2003